Hide

FocusBar

Subscribe to Premium Member
Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,003Revenue $M11.2Net Margin (%)-527.8Z-Score17.6
Enterprise Value $M830EPS $-1.0Operating Margin %-518.5F-Score4
P/E(ttm))0Cash Flow Per Share $-0.9Pre-tax Margin (%)-527.8Higher ROA y-yN
Price/Book10.410-y EBITDA Growth Rate %-20.5Quick Ratio3.8Cash flow > EarningsY
Price/Sales72.55-y EBITDA Growth Rate %-25.8Current Ratio5.2Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-47.1Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)1ROE % (ttm)-61.7Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M80.6ROI % (ttm)-55.5Gross Margin Increase y-yY

Gurus Latest Trades with CLDX

Please Subscribe to see portfolio changes after the end of the last quarter. Real Time Picks are included for Premium Members only! Plans start from as little as $299/year.

7-Day FREE TRIAL
Number of guru portfolios checked: 80. The trades of Premium Gurus are not included unless they are in your Personalized List

TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
CLDXJean-Marie Eveillard 2012-06-30 Add0.02%$3.9 - $5.26
($4.39)
$ 12.69189%Add 260.87%1,660,000
CLDXGeorge Soros 2012-06-30 Sold Out -0.06%$3.9 - $5.26
($4.39)
$ 12.69189%Sold Out0
CLDXGeorge Soros 2012-03-31 Buy 0.06%$2.77 - $5.46
($4)
$ 12.69217%New holding, 803200 sh.803,200
CLDXJean-Marie Eveillard 2012-03-31 Add0.01%$2.77 - $5.46
($4)
$ 12.69217%Add 360%460,000
CLDXJean-Marie Eveillard 2011-12-31 Reduce$2.11 - $3.21
($2.7)
$ 12.69370%Reduce -71.43%100,000
CLDXJean-Marie Eveillard 2011-06-30 Buy 0.01%$3.03 - $4.46
($3.75)
$ 12.69238%New holding, 350000 sh.350,000
CLDXJean-Marie Eveillard 2010-03-31 Sold Out $4.35 - $6.39
($4.93)
$ 12.69157%Sold Out0
CLDXJean-Marie Eveillard 2009-12-31 Buy $4.2 - $5.66
($4.78)
$ 12.69166%New holding, 100000 sh.100,000
CLDXJean-Marie Eveillard 2009-09-30 Sold Out $4.95 - $7.93
($6.35)
$ 12.69100%Sold Out0
CLDXJean-Marie Eveillard 2009-06-30 Buy $6.81 - $11.22
($8.56)
$ 12.6948%New holding, 50000 sh.50,000
CLDXJohn Hussman 2009-06-30 Sold Out $6.81 - $11.22
($8.56)
$ 12.6948%Sold Out0
CLDXJohn Hussman 2008-12-31 Buy $4.94 - $7.81
($6.3)
$ 12.69101%New holding, 13000 sh.13,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

CLDX is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
CLDX Jean-Marie Eveillard 2013-03-311,230,0211.530.05-16.36%
Premium Most recent portfolio changes are included for Premium Members only!


CLDX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
KELER TIBORSr. VP & CSO 2011-08-11Buy5,000$2.5407.6view
CATLIN AVERY WSr. VP & CFO 2011-08-09Buy2,000$2.39430.96view
Marucci Anthony SPresident & CEO 2011-08-09Buy15,000$2.41426.56view
Davis Thomas AndrewSr. VP & CMO 2010-09-16Buy2,500$3.77236.6view
LIPTON KAREN SHOOSDirector 2010-09-16Buy3,000$3.74239.3view
PAREKH RAJESH RDirector 2010-09-13Buy40,000$3.73240.21view
KELER TIBORSr. VP & CSO 2010-09-13Buy5,000$3.52260.51view
SHANNON TIMOTHY MDirector 2010-09-10Buy5,000$3.41272.14view
Marucci Anthony SPresident & CEO 2010-09-10Buy12,000$3.45267.83view
SCHALLER CHARLES RDirector 2010-09-09Buy5,000$3.45267.83view

Press Releases about CLDX:

Quarterly/Annual Reports about CLDX:

News about CLDX:

Articles On GuruFocus.com
CLDX up 223%, Cohen Gains Big Apr 23 2013 
Steve Cohen Increases Celldex Up 145% Apr 06 2013 
5 Resilient Biotech Stocks to Buy for 2012 Feb 28 2012 
CELLDEX THERAPEUTICS, INC (CLDX) CEO Anthony S Marucci buys 12,000 Shares Sep 13 2010 
Weekly CFO Buys Highlight: GNMK, RTIX, BKOR, PTEK, CLDX Sep 12 2010 
CELLDEX THERAPEUTICS, INC Reports Operating Results (10-Q) Aug 05 2010 
CELLDEX THERAPEUTICS, INC Reports Operating Results (10-Q) May 06 2010 
CELLDEX THERAPEUTICS, INC (CLDX) CFO Avery W Catlin buys 1,000 Shares Dec 01 2009 
Celldex Therapeutics Inc Reports Operating Results (10-Q) May 08 2009 

Add Notes, Comments or Ask Questions

Comments

No comment yet
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
Free 7-day Trial